Idarubicin
About Idarubicin
Idarubicin is a chemotherapy medication injected into a vein to treat acute myeloid leukemia, which is a type of blood cancer. It works by stopping cancer cells from growing and multiplying, helping to bring the disease into remission.
Because this medicine is given as an injection or infusion in a hospital or clinic, medical professionals will manage your schedule. Consistency is vital, and your healthcare team will plan your cycles carefully. Since it is injected, food intake does not directly affect how the drug is absorbed, but staying hydrated and eating small, frequent meals can help manage nausea.
Common side effects include nausea, temporary hair loss, and a decrease in blood cell counts, which can increase your risk of infections. You must consult your doctor immediately if you face specific serious side effects, such as signs of an infection (like a fever) or if you experience unusual chest pain.
Do not take this if you have severe liver damage, severe kidney damage, or severe heart problems, such as a recent heart attack or abnormal heart rhythms. It is also not suitable for individuals with severely weakened bone marrow function. Talk to your doctor before starting this medicine if you have any history of heart disease.
This medicine can interact with other cancer treatments, vaccines, and certain drugs that affect your heart or liver. Avoid live vaccines during treatment, and talk to your doctor if you are pregnant, breastfeeding, or planning a pregnancy, as this medicine can harm an unborn baby.
Uses of Idarubicin
Medicinal Benefits
Using Idarubicin as prescribed helps treat certain types of leukaemia by slowing the growth of cancer cells. Here are the key benefits you can expect:
- Helps destroy leukaemia cells: Targets rapidly dividing cancer cells, helping reduce their number in the blood and bone marrow.
- Supports healthy blood cell production: As abnormal cells decrease, the bone marrow can gradually produce healthy red blood cells, white blood cells, and platelets.
- Works well with combination therapy: When used with other chemotherapy medicines, Idarubicin helps improve treatment effectiveness and supports better disease control.
Directions for Use
- Follow your doctor’s instructions on the dosage and timing of this medication to ensure safety.
- Idarubicin will be administered by the doctor or healthcare professional.
- Do not self-administer.
Storage
Side Effects of Idarubicin
Common Side Effects (Usually mild):
- Nausea and vomiting
- Temporary hair loss
- Upset stomach, diarrhoea, or mouth sores
- Feeling unusually tired or weak
Serious Side Effects (Consult your doctor right away):
- Signs of infection, such as a high fever, chills, sore throat, or cough
- Unusual bruising, easy bleeding, or small red spots under the skin
- Chest pain, fast or irregular heartbeat, or sudden shortness of breath
- Severe pain, redness, or swelling at the injection site
- Yellowing of the eyes or skin, which could indicate liver damage
Medicines Containing this Salt
View AllDrug Warnings
- Watch the injection site closely: Let your nurse or doctor know immediately if you feel any burning, stinging, pain, or redness around the IV line during the injection. Leaking can cause severe tissue damage.
- Monitor your temperature daily: A fever is a medical emergency when you are on this medicine. Contact your healthcare team right away if your temperature rises.
- Expect urine discolouration: Do not be alarmed if your urine turns a reddish colour for a day or two after your injection; this is a harmless side effect of the medicine clearing your body.
- Avoid contact with body fluids: Since the drug remains in your system for a few days, flush the toilet twice after use and wash your hands thoroughly to protect others in your household.
- Have regular heart checks: Your doctor will schedule regular tests, such as echocardiograms, to monitor your heart health before and during your treatment cycles.
Drug Interactions
- Other heart-affecting cancer treatments or chest radiotherapy: May increase the risk of heart damage when used together with Idarubicin.
- Live vaccines or immunosuppressive medicines: May increase the risk of serious infections and should generally be avoided during treatment.
Drug-Drug Interactions Checker List:
Safety Advice
Alcohol
unsafeAvoid consumption of alcohol with Idarubicin as it may increase the risk of liver damage.
Pregnancy
unsafeIt is not recommended for use in pregnancy as it may harm your foetus. If you are pregnant or planning pregnancy, inform your doctor before receiving Idarubicin. Use effective contraception to avoid pregnancy while on treatment with this medicine.
Breast Feeding
unsafeIt is not recommended for use in breastfeeding as it may pass into breast milk and harm your infant. Because of the possibility of major adverse events in nursing infants from the medicine, women should quit nursing prior to taking the drug and refrain from breastfeeding during treatment and for 14 days after the final dosage.
Driving
unsafeIdarubicin causes dizziness and may alter the ability to drive or operate machines. Hence, avoid driving or operating machines after taking Idarubicin.
Liver
cautionIf you have a pre-existing or a history of liver disease, inform your doctor before receiving Idarubicin. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition. Your doctor may also suggest liver function tests while on treatment with Idarubicin.
Kidney
cautionIf you have a pre-existing or a history of kidney disease, inform your doctor before receiving Idarubicin. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition. Your doctor may also suggest renal function tests while on treatment with Idarubicin.
Children
unsafeIdarubicin is not recommended for use in children as the safety and efficacy have not been established.
Habit Forming
Diet & Lifestyle Advise
- Follow a clean, fully cooked diet: To protect your immune system when your white blood cell count is low, avoid raw foods, unpasteurized dairy, and unwashed fruits or vegetables.
- Stay well-hydrated: Drink plenty of fluids, such as water or clear broths, to help your kidneys flush out the waste products from destroyed cancer cells.
- Eat small, frequent meals: If you experience nausea, eating smaller portions throughout the day rather than three large meals can help maintain your nutrition and energy levels.
- Maintain excellent oral hygiene: Use a soft-bristled toothbrush and a mild, alcohol-free mouthwash to prevent mouth sores and infections.
- Avoid crowds and sick people: Because your body's ability to fight infections will be reduced, try to steer clear of crowded public spaces and anyone who is currently unwell.
Special Advise
- Idarubicin is intended for intravenous administration only.
- This medicine should be administered only by a well-trained and experienced oncologist in a hospital setting.
- Regular blood tests are recommended while receiving Idarubicin to monitor the number and type of cells in the blood, liver and kidney functioning.
- Cardiac function should be monitored carefully. Regular ECG should be done to check for any changes.
Patients Concern
Disease/Condition Glossary
Acute Myeloid Leukemia (AML): It is a type of cancer that occurs in the bone marrow and blood. It abnormally increases the number of immature white blood cells. The symptoms include unexplained weight loss, excessive sweating, bone pain, frequent nosebleeds, heavier-than-normal periods in females, and shortness of breath. The risk factors include smoking and genetic or blood disorders.
FAQs
Idarubicin is used to treat Acute Myeloid Leukemia.
Idarubicin contains Idarubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, destroying DNA and RNA synthesis.
Yes, Idarubicin is a vesicant. Vesicants are drugs that can cause severe tissue damage and blistering if they leak out of the vein during administration (a process known as extravasation). Always ensure Idarubicin should be administered by trained healthcare professionals to minimize risks.
The side effects of Idarubicin include nausea, vomiting, mouth ulcers, loss of appetite, diarrhoea, dizziness, weakness, stomach pain, headache, pale skin, difficulty urinating, fever, and pain at the injection site. Consult the doctor if any of these symptoms persist or worsen.
This medicine is injected directly into a vein as an infusion by a healthcare provider in a hospital or specialised clinic. Talk to your doctor if you have questions about your specific treatment schedule.
Yes, temporary hair loss is a very common side effect of this chemotherapy medicine. Your hair will typically begin to grow back after your treatment cycles are completed. Talk to your doctor or nurse about managing this change.
This medicine has a natural reddish color, which can tint your urine pink or red for up to 48 hours after your injection. This is a normal, harmless occurrence as your body eliminates the drug. Talk to your doctor if this lasts longer than a few days.
You should avoid receiving live vaccines during your treatment, as your weakened immune system may not be able to handle them safely. Always consult your healthcare team before getting any vaccine. Talk to your doctor for a safe vaccination schedule.
This medicine temporarily lowers the number of white blood cells, red blood cells, and platelets in your body, which can increase your risk of infections, fatigue, and bleeding. Your medical team will monitor your blood counts regularly. Talk to your doctor about how to protect yourself during this time.
Since this medicine can cause severe fatigue, nausea, or dizziness, it is highly recommended that you arrange for someone else to drive you home after your appointment. Talk to your doctor about how this medication might affect your daily activities.
This class of medication can sometimes affect the heart muscle, especially at higher cumulative doses. Your doctor will run regular tests to monitor your heart function throughout your treatment. Talk to your doctor if you experience chest pain, shortness of breath, or a rapid heart rate.
No, you should not breastfeed while receiving this medicine, as it can pass into breast milk and potentially harm your baby. Talk to your doctor about safe feeding alternatives for your infant.
Author Details
